e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Interstitial lung diseases II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Fatma Tokgöz Akyil (Istanbul, Turkey), Fatma Tokgöz Akyil, Tülin Sevim, Hakan Kiral, Emine Aksoy, Mustafa Vayvada, Mustafa Akyil, Dilem Anil Tokyay, Volkan Baysungur
Source:
International Congress 2015 – Interstitial lung diseases II
Session:
Interstitial lung diseases II
Session type:
Thematic Poster Session
Number:
3835
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Fatma Tokgöz Akyil (Istanbul, Turkey), Fatma Tokgöz Akyil, Tülin Sevim, Hakan Kiral, Emine Aksoy, Mustafa Vayvada, Mustafa Akyil, Dilem Anil Tokyay, Volkan Baysungur. What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?. Eur Respir J 2015; 46: Suppl. 59, 3835
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Related content which might interest you:
The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease
Source: International Congress 2015 – Challenges in surgery for non-malignant disorders: pleural mediastinal and tracheal problems, congenital disorders
Year: 2015
Diagnostic utility of surgical lung biopsies in elderly patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Transbronchial cryobiopsy for the diagnosis of interstitial lung disease (ILD) – The UK experience
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Interstitial fibrosis with a nodule
Source: Annual Congress 2007 - Thoracic Oncology Grand Round: an interactive session
Year: 2007
Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008
Does emphysema coexistence with IPF change prognosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Diagnostic value of video-assisted thoracoscopic lung biopsy on diagnosis of diffuse parenchymal lung dissease
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Prospective study of feasibility and safety of bronchoscopic transbronchial cryprobe biopsies in interstitial lung disease: Initial experience of an Irish interstitial lung disease centre
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Using the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept